# Metformin And Chloroquine in IDH1/2-mutated Solid Tumors

> **NCT02496741** · PHASE1,PHASE2 · COMPLETED · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 15 (actual)

## Conditions studied

- Glioma
- Cholangiocarcinoma
- Chondrosarcoma

## Interventions

- **DRUG:** Metformin and chloroquine combination

## Key facts

- **NCT ID:** NCT02496741
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2019-11-18
- **Final completion:** 2019-11-18
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2020-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02496741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02496741, "Metformin And Chloroquine in IDH1/2-mutated Solid Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02496741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*